These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4512655)

  • 1. Possible immunosuppressive effect of Corynebacterium parvum on infection with Trichinella spiralis.
    Ruitenberg EJ; Steerenberg PA
    Nat New Biol; 1973 Apr; 242(118):149-50. PubMed ID: 4512655
    [No Abstract]   [Full Text] [Related]  

  • 2. Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers.
    Sawyer RT; Moon RJ; Beneke ES
    Infect Immun; 1981 May; 32(2):945-50. PubMed ID: 7019084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Corynebacterium parvum on liver proliferation and regeneration.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Cancer Res; 1979 Apr; 39(4):1361-8. PubMed ID: 421219
    [No Abstract]   [Full Text] [Related]  

  • 4. The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.
    Woodruff M; Dunbar N; Ghaffar A
    Proc R Soc Lond B Biol Sci; 1973 Aug; 184(1074):97-102. PubMed ID: 4147951
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Corynebacterium parvum bacterin on artificial immunity against Babesia rodhaini infection in mice.
    Saeki H; Ishii T
    Nihon Juigaku Zasshi; 1989 Dec; 51(6):1255-7. PubMed ID: 2601237
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 7. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
    Keller R
    J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hydrocortisone on the immune response of mice treated with Corynebacterium parvum.
    Greenberg CS; Dimitrov NV
    Clin Immunol Immunopathol; 1976 Mar; 5(2):264-71. PubMed ID: 776469
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-specific immunization against bovine tropical theileriosis (Theileria annulata) using killed Corynebacterium parvum.
    Manickam R; Dhar S; Singh RP
    Vet Parasitol; 1983 Sep; 13(2):115-9. PubMed ID: 6685397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice.
    Kirchner H; Chmielarczyk W; Storch E; Schindler L
    Behring Inst Mitt; 1984 May; (74):183-8. PubMed ID: 6206840
    [No Abstract]   [Full Text] [Related]  

  • 11. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects on the lymphreticular system and inhibition of liver microsomaal cytochrome P-450 in mice administered Priopionibacterium acnes (Corynebacterium parvum) bacterin].
    Ocenásková J; Mára M; Bednár M; Veselská M; Adamcová D
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):100-6. PubMed ID: 3157461
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Corynebacterium parvum and anaesthetics.
    Farquhar D; Loo TL; Reed R; Luna M
    Lancet; 1975 Apr; 1(7912):914. PubMed ID: 47551
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of the non-specific resistance by Corynebacterium parvum and Bacillus calmette Guérin.
    Ruitenberg EJ; Steerenberg PA
    Tijdschr Diergeneeskd; 1976 Jul; 101(14):775-8. PubMed ID: 821172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum.
    Soyka LF; Stephens CC; MacPherson BR; Foster RS
    Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of preadministration of Corynebacterium parvum on the protection afforded by heat-killed and acetone-killed vaccines against experimental mouse typhoid.
    Cronly-Dillon S
    J Hyg (Lond); 1974 Feb; 72(1):13-8. PubMed ID: 4593737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Corynebacterium parvum vaccine in conjunction with immunosuppression in renal transplant in dogs.
    Munda R; Alexander JW; Stinnett JD; Weiss MA; Morris MJ
    Transplantation; 1982 Mar; 33(3):333-5. PubMed ID: 7039044
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage activation and increased resistance to infection in immunosuppressed mice treated with Corynebacterium parvum vaccine or pyran copolymer.
    Stinnett JD; Morris MJ; Alexander JW
    J Reticuloendothel Soc; 1979 May; 25(5):525-31. PubMed ID: 458782
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of Corynebacterium parvum and Corynebacterium liquefaciens on antitumor activity against sarcoma-180.
    Ideda H; Yamagata S; Toge T; Hattori T
    Gan; 1977 Apr; 68(2):233-5. PubMed ID: 892298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.